The federal regulator sent warning letters to five companies for marketing pills and capsules that make unproven claims they protect people from the sun. » Read More
By: Andrew Zaleski
Bill Gates is investing in Ginkgo Bioworks, a Boston-based start-up that prints synthetic DNA from a computer and is developing one of the world's largest libraries of usable designer genetic code. » Read More
By: Christina Farr
Disruptor 50 start-up Oscar Health told CNBC that it has a strategy in place to make money and improve the health-care experience for members. » Read More
People who eat an egg just about every day may have a lower risk of heart attack and stroke than individuals who don't eat eggs at all, a large Chinese study suggests.
The rate of people without health insurance is still well lower than when the Affordable Care Act was passed in 2010.
The spread of Ebola to a major city in Democratic Republic of Congo is worrying but the outlook is much more optimistic than when a major outbreak was reported in West Africa in 2014.
Biotech companies and pharmacy benefit managers are outperforming the market, despite new pressure on drugmakers.
HCA Healthcare and KKR have joined forces to make an offer for U.S. physician services provider Envision Healthcare, people familiar with the matter said.
Roche's new hemophilia drug Hemlibra dramatically reduced bleeding in a broad population of hemophilia patients, results from two clinical trials showed.
New York resident Rodney Nelson says his 77-year-old mother wanted to maintain her independence while also getting the support she needs.
The Department of Veterans Affairs has been accused of being too bureaucratic to function, and nobody can seem to lead it for much longer than a few years. But the VA hasn’t always been struggling. So just when did things go so wrong for the VA?
Krishna Yeshwant is a venture capitalist and doctor who has a crafty way to think through his health-tech investments.
A statement late Friday said the confirmed cases are in Mbandaka city, where a single case was confirmed earlier in the week.
Aimovig from Amgen and Novartis could become a $1 billion to $2 billion business in five years, say one Wall Street analyst.
Johnson and Johnson said it would stop mid-stage trials testing its experimental Alzheimer's drug after observing safety issues.
Major pharmaceutical companies have spent billions of dollars in an effort to patent their products and avoid generic copies of blockbuster medicines, but the FDA commissioner has vowed to end this, the New York Times reports.
A number of behavioral factors explain why it's so hard to ignore free food in the office, but you can do a few things to improve your chances of resisting.
As would-be parents push back parenthood, companies that provide baby products are feeling the pinch.
Bill Gates says President Trump twice asked him the difference between HPV and HIV.
Get the best of CNBC in your inbox